» Articles » PMID: 39241017

The DNA Loop Release Factor WAPL Suppresses Epstein-Barr Virus Latent Membrane Protein Expression to Maintain the Highly Restricted Latency I Program

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2024 Sep 6
PMID 39241017
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) uses latency programs to colonize the memory B-cell reservoir, and each program is associated with human malignancies. However, knowledge remains incomplete of epigenetic mechanisms that maintain the highly restricted latency I program, present in memory and Burkitt lymphoma cells, in which EBNA1 is the only EBV-encoded protein expressed. Given increasing appreciation that higher order chromatin architecture is an important determinant of viral and host gene expression, we investigated roles of Wings Apart-Like Protein Homolog (WAPL), a host factor that unloads cohesin to control DNA loop size and that was discovered as an EBNA2-associated protein. WAPL knockout (KO) in Burkitt cells de-repressed LMP1 and LMP2A expression, but not other EBV oncogenes, to yield a viral program reminiscent of EBV latency II, which is rarely observed in B-cells. WAPL KO also increased LMP1/2A levels in latency III lymphoblastoid cells. WAPL KO altered EBV genome architecture, triggering formation of DNA loops between the LMP promoter region and the EBV origins of lytic replication (oriLyt). Hi-C analysis further demonstrated that WAPL KO reprogrammed EBV genomic DNA looping. LMP1 and LMP2A de-repression correlated with decreased histone repressive marks at their promoters. We propose that EBV coopts WAPL to negatively regulate latent membrane protein expression to maintain Burkitt latency I.

References
1.
RABSON M, Gradoville L, Heston L, Miller G . Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol. 1982; 44(3):834-44. PMC: 256340. DOI: 10.1128/JVI.44.3.834-844.1982. View

2.
Wille C, Li Y, Rui L, Johannsen E, Kenney S . Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. J Virol. 2016; 91(5). PMC: 5309966. DOI: 10.1128/JVI.01987-16. View

3.
Konforte D, Simard N, Paige C . Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells. Virology. 2008; 374(1):100-13. DOI: 10.1016/j.virol.2007.12.027. View

4.
Longnecker R, Kieff E . A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol. 1990; 64(5):2319-26. PMC: 249393. DOI: 10.1128/JVI.64.5.2319-2326.1990. View

5.
Beckouet F, Srinivasan M, Roig M, Chan K, Scheinost J, Batty P . Releasing Activity Disengages Cohesin's Smc3/Scc1 Interface in a Process Blocked by Acetylation. Mol Cell. 2016; 61(4):563-574. PMC: 4769318. DOI: 10.1016/j.molcel.2016.01.026. View